Home Cart Sign in  
Chemical Structure| 30757-50-7 Chemical Structure| 30757-50-7

Structure of 30757-50-7

Chemical Structure| 30757-50-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 30757-50-7 ]

CAS No. :30757-50-7
Formula : C8H4N2O
M.W : 144.13
SMILES Code : OC1=CC=C(C#N)C(C#N)=C1
MDL No. :MFCD00191653
InChI Key :FTVOPKROFUTOKY-UHFFFAOYSA-N
Pubchem ID :3875765

Safety of [ 30757-50-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 30757-50-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 0
Num. H-bond acceptors 3.0
Num. H-bond donors 1.0
Molar Refractivity 37.9
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

67.81 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.01
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.15
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.14
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.15
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.29
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.95

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.86
Solubility 1.98 mg/ml ; 0.0137 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.17
Solubility 0.978 mg/ml ; 0.00678 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.97
Solubility 1.54 mg/ml ; 0.0107 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

Yes
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.36 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.25

Application In Synthesis of [ 30757-50-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 30757-50-7 ]

[ 30757-50-7 ] Synthesis Path-Downstream   1~36

  • 1
  • [ 78-83-1 ]
  • [ 31643-49-9 ]
  • [ 30757-50-7 ]
  • [ 96917-81-6 ]
  • 2
  • [ 77-84-9 ]
  • [ 31643-49-9 ]
  • [ 30757-50-7 ]
  • [ 93673-02-0 ]
  • 3
  • [ 31643-49-9 ]
  • [ 30757-50-7 ]
YieldReaction ConditionsOperation in experiment
85% 1) A three-necked flask was charged with 103.9 g (600 mmo 1) of 4-nitro phthalonitrile, 800 mL of dimethyl sulfoxideAfter the powder was dissolved, 91.0 g (660 mmol) of potassium carbonate and 46.0 g (660 mmol) of sodium nitrite were added and heated at reflux to 160 C for 5 hours. After cooling to room temperature, the mixture was poured into a large amount of water, A yellow solid was precipitated and evacuated at 110 C and dried in vacuo to give 73.3 g of 4-hydroxy phthalonitrile in 85% yield.
  • 4
  • [ 31643-49-9 ]
  • [ 30757-50-7 ]
  • [ 23277-29-4 ]
  • 2-cyano-4-nitrobenzoic acid [ No CAS ]
  • 5
  • [ 615-56-5 ]
  • [ 544-92-3 ]
  • [ 30757-50-7 ]
  • 6
  • [ 109-87-5 ]
  • [ 30757-50-7 ]
  • 4-methoxymethoxyphthalonitrile [ No CAS ]
  • 7
  • [ 462-95-3 ]
  • [ 30757-50-7 ]
  • 4-ethoxymethoxyphthalonitrile [ No CAS ]
  • 8
  • [ 109-65-9 ]
  • [ 30757-50-7 ]
  • 3,5-dibromo-4-hydroxyphthalonitrile [ No CAS ]
  • 3-bromo-4-butoxyphthalonitrile [ No CAS ]
  • 4-bromo-5-butoxyphthalonitrile [ No CAS ]
  • 9
  • [ 30757-50-7 ]
  • 4-bromo-5-hydroxyphthalonitrile [ No CAS ]
  • 3-bromo-4-hydroxyphthalonitrile [ No CAS ]
  • 3,5-dibromo-4-hydroxyphthalonitrile [ No CAS ]
  • 10
  • [ 30757-50-7 ]
  • 4-hydroxy-5-iodophthalonitrile [ No CAS ]
  • 4-hydroxy-3,5-diiodophthalonitrile [ No CAS ]
  • 11
  • [ 30757-50-7 ]
  • [ 168299-95-4 ]
  • 4-hydroxy-3-nitrophthalonitrile [ No CAS ]
  • 12
  • [ 3970-21-6 ]
  • [ 30757-50-7 ]
  • 4-(2-methoxy-ethoxymethoxy)-phthalonitrile [ No CAS ]
  • 14
  • [ 112-16-3 ]
  • [ 30757-50-7 ]
  • dodecanoic acid 3,4-dicyano-phenyl ester [ No CAS ]
  • 15
  • [ 30757-50-7 ]
  • [ 67590-11-8 ]
  • 4-undecyloxy-benzoic acid 3,4-dicyano-phenyl ester [ No CAS ]
  • 16
  • [ 108-22-5 ]
  • [ 30757-50-7 ]
  • acetic acid 3,4-dicyano-phenyl ester [ No CAS ]
  • 17
  • [ 30757-50-7 ]
  • (NC4C4H2)4N4(OH)4H4(2-)*Al(3+)*Cl(1-) [ No CAS ]
  • 18
  • [ 30757-50-7 ]
  • (NC4C4H2)4N4(OH)4H4(2-)*In(3+)*Cl(1-) [ No CAS ]
  • 19
  • [ 30757-50-7 ]
  • (NC4C4H2)4N4(OH)4H4(2-)*Cr(3+)*Cl(1-) [ No CAS ]
  • 20
  • [ 30757-50-7 ]
  • (NC4C4H2)4N4(OH)4H4(2-)*Sn(4+)*2Cl(1-) [ No CAS ]
  • 21
  • [ 350793-49-6 ]
  • [ 30757-50-7 ]
  • 2-(3,4-dicyanophenoxy)ethyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside [ No CAS ]
  • 22
  • 2-(tosyloxy)ethyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside [ No CAS ]
  • [ 30757-50-7 ]
  • 2-(3,4-dicyanophenoxy)ethyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside [ No CAS ]
  • 23
  • [ 86312-75-6 ]
  • [ 30757-50-7 ]
  • 24
  • [ 30757-50-7 ]
  • 4-methoxy-5-nitrophthalonitrile [ No CAS ]
  • 25
  • [ 30757-50-7 ]
  • 4-methoxy-3-nitrophthalonitrile [ No CAS ]
  • 26
  • [ 13138-53-9 ]
  • [ 30757-50-7 ]
  • 27
  • 1-(5-cyanobenzoxazol-2-yl)-2-methylpropyl bromide [ No CAS ]
  • [ 30757-50-7 ]
  • 1-(5-cyanobenoxazol-2-yl)-1-(3,4-dicyanophenoxy)-2-methylpropane [ No CAS ]
  • 28
  • 2,5-trans-methylpiperazine [ No CAS ]
  • [ 30757-50-7 ]
  • trans-4-(2,5-Dimethylpiperazin-1-yl)phthalonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
With trifluorormethanesulfonic acid; triethylamine; In ethyl acetate; N,N-dimethyl-formamide; acetonitrile; Reference Example 8 trans-4-(2,5-Dimethylpiperazin-1-yl)phthalonitrile A 1.52 g portion of <strong>[30757-50-7]4-hydroxyphthalonitrile</strong> was dissolved in 30.0 ml of acetonitrile, mixed with 2.1 ml of triethylamine and stirred at -10C. The reaction solution was mixed with 1.8 ml of anhydrous trifluoromethanesulfonic acid, stirred at 0C for 30 minutes and then warmed up to room temperature, mixed with 15 ml of DMF and stirred for 2 hours. After evaporation of the solvent under reduced pressure, the residue was mixed with ethyl acetate and washed with saturated aqueous sodium bicarbonate and then the organic layer was dried over sodium sulfate. After evaporation of the solvent under reduced pressure, the residue was dissolved in 20 ml of acetonitrile and mixed with 2.30 g of 2,5-trans-methylpiperazine, and the mixture was heated under reflux for 2 hours and then stirred overnight at room temperature. After evaporation of the solvent under reduced pressure, the residue was mixed with 100 ml of ethyl acetate, washed with saturated aqueous sodium bicarbonate and saturated brine and then dried over sodium sulfate. The title compound was obtained by evaporating the solvent under reduced pressure.
  • 29
  • [ 7787-87-3 ]
  • [ 30757-50-7 ]
  • [ 91-15-6 ]
YieldReaction ConditionsOperation in experiment
77.0% With hydrogenchloride; potassium carbonate; In N,N-dimethyl-formamide; Preparation Example 4 Preparation of Phthalonitrile : In 200 ml of N,N-dimethylformamide were dissolved with heating 20 g of <strong>[30757-50-7]4-hydroxyphthalonitrile</strong> and 10.55 g of potassium carbonate, to which 20 g of chloroethyl- trimethylsilane were added dropwise at 40C in the atmosphere of argon. Immediately after the addition, the mixture was stirred for 18 hours while maintaining the reaction temperature at 85-105C. The reaction vessel was then cooled to room temperature and 250 ml of dilute hydrochloric acid was added. The mixture was extracted with 1.2 liters of toluene. The organic layer was washed well with water and water was removed with magnesium sulfate. Thereafter, toluene was removed by distillation and the residue was purified with a toluene/silica gel column to obtain 24.6 g (yield: 77.0 %) of a compound having the formula (XVII) below.
  • 30
  • [ 30757-50-7 ]
  • [ 152333-94-3 ]
  • 4-(2-oxiranylmethoxy)phthalonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
With potassium carbonate; In acetonitrile; (a) 4-(2-Oxiranylmethoxy)phthalonitrile A stirred suspension of <strong>[30757-50-7]4-hydroxyphthalonitrile</strong> (3.5 g; 24.3 mmol), K2CO3 (4.03 g; 29.2 mmol) and 2-[(3-nitrophenyl)sulfonyloxy]methyl}-oxirane (6.50 g; 25.0 mmol; see Example B above) in MeCN (170 mL) was refluxed for 1.5 h. The cooled reaction mixture was filtered, the filtrate concentrated and the solid residue recrystallized from IPA to give the sub-title compound.
  • 32
  • [ 30757-50-7 ]
  • [ 50625-44-0 ]
  • [ 1122708-61-5 ]
  • 33
  • [ 30757-50-7 ]
  • [ 122-04-3 ]
  • [ 1122708-69-3 ]
  • 36
  • [ 30757-50-7 ]
  • [ 65-85-0 ]
  • [ 330675-38-2 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 30757-50-7 ]

Aryls

Chemical Structure| 14143-26-1

A130509 [14143-26-1]

4-Hydroxy-2-methylbenzonitrile

Similarity: 1.00

Chemical Structure| 58537-99-8

A170112 [58537-99-8]

4-Hydroxy-2,6-dimethylbenzonitrile

Similarity: 0.97

Chemical Structure| 55289-04-8

A235823 [55289-04-8]

3-Hydroxy-2-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 73289-66-4

A208928 [73289-66-4]

2-Hydroxy-6-methylbenzonitrile

Similarity: 0.92

Chemical Structure| 95658-81-4

A117413 [95658-81-4]

3-Hydroxy-5-methylbenzonitrile

Similarity: 0.92

Nitriles

Chemical Structure| 14143-26-1

A130509 [14143-26-1]

4-Hydroxy-2-methylbenzonitrile

Similarity: 1.00

Chemical Structure| 58537-99-8

A170112 [58537-99-8]

4-Hydroxy-2,6-dimethylbenzonitrile

Similarity: 0.97

Chemical Structure| 55289-04-8

A235823 [55289-04-8]

3-Hydroxy-2-methylbenzonitrile

Similarity: 0.95

Chemical Structure| 73289-66-4

A208928 [73289-66-4]

2-Hydroxy-6-methylbenzonitrile

Similarity: 0.92

Chemical Structure| 95658-81-4

A117413 [95658-81-4]

3-Hydroxy-5-methylbenzonitrile

Similarity: 0.92